NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Cardiovascular > Research suggests high blood pressure is major cause of heart valve disease

Research suggests high blood pressure is major cause of heart valve disease

10 July 2019 · Listed under Cardiovascular, Multimorbidity and Long-Term Conditions

New research has conclusively found that long-term exposure to high blood pressure increases the risk of heart valve disease, with significant implications for clinical practice guidelines and health management.

“Clinical practice guidelines currently make little reference to preventative strategies for major valvular heart diseases, but this study highlights that high blood pressure should be considered a major risk factor, much as it is for heart attacks, stroke and other cardiovascular conditions,” said Lead Researcher Milad Nazarzadeh, of The George Institute for Global Health, UK and Oxford Martin School’s Deep Medicine programme at the University of Oxford.

“A few earlier studies suggested that experiencing high blood pressure is associated with an increased risk of valvular heart disease, but whether the observed associations were causal was uncertain. In this study, we have expanded upon previous work and confirm that exposure to high blood pressure substantially increases the chances of major valvular disease, including aortic stenosis, aortic regurgitation and mitral regurgitation.”

The findings are from a study of half a million men and women in the UK aged between 40 to 96 years from the UK Biobank study.

The study, published in the JAMA Cardiology journal today (10 July), was supported by the NIHR Oxford Biomedical Research Centre.

The research team used a state-of-the-art gene-based method called Mendelian randomisation to prove this causal link. Since birth, we all either have genes that are known to be associated with a propensity for normal or high blood pressure in later life.

Researchers were therefore able to group study participants based on their genetic blood pressure characteristics and then directly compare outcomes in terms of risk of major valvular diseases in the knowledge that this risk was solely related to blood pressure and not to any other factors.

The findings reveal that:

  • Each 20 mmHg increase in systolic blood pressure roughly equates to a threefold increase in the odds of developing aortic stenosis, a condition in which the valve that controls how blood is pumped from the heart to the main artery doesn’t open fully.
  • A similar pattern of association was observed for two other major heart valve conditions, aortic regurgitation and mitral regurgitation.

Patients with heart valve disease may suffer symptoms such as irregular heartbeat, shortness of breath, fatigue, fainting and dizziness.

The new research provides further evidence of the importance of controlling high blood pressure, and doing so at the earliest opportunity, to limit the time that individuals are exposed to the condition.  

As well as the Oxford BRC, the study was funded by the Oxford Martin School at the University of Oxford, the UKRI’s Global Challenges Research Fund, and by the British Heart Foundation.

← Women and older people most likely to experience shortcomings in heart failure care
New approach to reducing damage after a heart attack →

News

  • Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination 24 May 2022
  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre